OQS
AYTU icon

Occudo Quantitative Strategies’s AYTU BioPharma AYTU Stock Holding History

Occudo Quantitative Strategies’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,062
Closed -$83K – 1126
2021
Q4 		$83K Sell
3,062
-601
-16% -$26K 0.01% 974
2021
Q3 		$211K Buy
3,663
+617
+20% +$46.3K 0.03% 846
2021
Q2 		$305K Buy
3,046
+40
+1% +$4.69K 0.05% 587
2021
Q1 		$457K Buy
+3,006
New +$477K 0.1% 356

Other funds holding AYTU

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Occudo Quantitative Strategies's AYTU Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of AYTU BioPharma (AYTU) in Q1 2022, closing a stake of 3,062 shares — an estimated $83K sold.

Occudo Quantitative Strategies first reported a position in AYTU in Q1 2021 and held it in 4 quarters. The position peaked at $457K in Q1 2021. 32 funds tracked by Wall St. Rank hold AYTU as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining AYTU BioPharma position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 3,062 AYTU BioPharma shares in Q1 2022, an estimated $83K.
  • Occudo Quantitative Strategies first reported a position in AYTU BioPharma in Q1 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's AYTU BioPharma position peaked at $457K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.